FNYS
CYNA

First New York Securities’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

First New York Securities’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-223,606
Closed -$9M – 278
2016
Q3 		$9M Buy
+223,606
New +$5.52M 5.95% 3

First New York Securities's CYNA Position: Q4 2016 in Review

First New York Securities sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 223,606 shares — an estimated $9M sold.

First New York Securities first reported a position in CYNA in Q3 2016 and held it in 1 quarter. The position peaked at $9M in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

  • First New York Securities reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
  • First New York Securities sold 223,606 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $9M.
  • First New York Securities first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2016 and held it in 1 quarter.
  • First New York Securities's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $9M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on First New York Securities's 13F filing for Q4 2016, filed 7 Feb 2017.